DISCLOSURE RECEIVED FROM MR. SUDHIR SETHI UNDER REGULATION 29(2) OF SEBI (SUBSTANTIAL ACQUISITION OF SHARES AND TAKEOVERS) REGULATIONS, 2011
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mr. Sudhir Sethi, the main promoter of Beryl Drugs Ltd, has acquired 15,000 equity shares (0.29% of total share capital) through open market transactions on 12-03-2026. Following this acquisition, his holding in the company has increased from 4,55,143 shares (8.98%) to 4,70,143 shares (9.27%). The total share capital of the company remains unchanged at 50,71,700 shares. This is a small, incremental purchase by the promoter and falls under the disclosure requirement of Regulation 29(2) of SEBI Takeover Regulations.
This is a minor, confidence-inspiring signal as the promoter is buying shares from the open market, though the small size (0.29%) suggests routine portfolio adjustment rather than a major strategic move. Shareholders may view it as a mild positive given the promoter is approaching the 10% substantial shareholder disclosure threshold.